Treatments for Epilepsy: An Analysis of Recent Literature

Abstract

The text provides a comprehensive analysis of the various therapeutic approaches to epilepsy, highlighting both significant advancements made and persistent challenges that remain in this area. While the identification of potential therapeutic targets through an understanding of epilepsy genetics has been a crucial breakthrough, current antiepileptic medications face significant limitations, such as limited long-term efficacy and adverse side effects. This underscores the urgent need for therapeutic innovation, addressing not only genetic aspects but also the pathophysiology of the disease. Diversified therapeutic alternatives, such as surgery, special diets, and neuromodulation therapies, offer hope for medication-resistant patients. Additionally, emerging approaches like chronopharmacology and the use of cannabidiol show promise, albeit requiring further research to validate their efficacy and safety. The growing understanding of the role of the intestinal microbiota in epilepsy also suggests new therapeutic possibilities, despite gaps in our understanding of underlying mechanisms. In summary, a personalized, multidisciplinary approach, coupled with collaborations between researchers, physicians, and the industry, is essential to translate scientific advancements into more effective and accessible therapies, offering hope for a better future for all epilepsy patients.